Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The major cardiac voltage-gated sodium channel
Nav1.5
associates with proteins that regulate its biosynthesis, localization, activity and degradation. Identification of partner proteins is crucial for a better understanding of the channel regulation. Using a yeast two-hybrid screen, we identified dynamitin as a
Nav1.5
-interacting protein. Dynamitin is part of the microtubule-binding multiprotein complex dynactin. When overexpressed it is a potent inhibitor of dynein/
kinesin
-mediated transport along the microtubules by disrupting the dynactin complex and dissociating cargoes from microtubules. The use of deletion constructs showed that the C-terminal domain of dynamitin is essential for binding to the first intracellular interdomain of
Nav1.5
. Co-immunoprecipitation assays confirmed the association between
Nav1.5
and dynamitin in mouse heart extracts. Immunostaining experiments showed that dynamitin and
Nav1.5
co-localize at intercalated discs of mouse cardiomyocytes. The whole-cell patch-clamp technique was applied to test the functional link between
Nav1.5
and dynamitin. Dynamitin overexpression in HEK-293 (human embryonic kidney 293) cells expressing
Nav1.5
resulted in a decrease in sodium current density in the membrane with no modification of the channel-gating properties. Biotinylation experiments produced similar information with a reduction in
Nav1.5
at the cell surface when dynactin-dependent transport was inhibited. The present study strongly suggests that dynamitin is involved in the regulation of
Nav1.5
cell-surface density.
...
PMID:Dynamitin affects cell-surface expression of voltage-gated sodium channel Nav1.5. 2508 59